InsidersTradesSigma
Nykode Therapeutics ASA: management transactions · Norway · Oslo Børs
OSLO:nykode-therapeutics-asaNO·Oslo Børs
Browse the full insider trade history of Nykode Therapeutics ASA, a listed issuer based in Norway. Shares are quoted on NO NO, under the authority of Oslo Børs. The latest transaction was filed on 30 January 2026 (Option grant). Among the most active insiders: Unknown insider (NYKD). All data is free.
52
Insider Decl.
0
Thresholds
€47m
25 ops.
Buy Volume
€23m
9 ops.
Sell Volume
Financial data
3.25 €
Last declaration on 30 January 2026
Declarations52 total
Executives◇Options11Oslo
€367,681600,000 shares@ €0.6128100.0% of flow
OptionXOSL
OSLO:664566·
Executives●Purchase0Oslo
€8,49046,356 shares@ €0.1831
ShareXOSL
OSLO:660428·
Ideal exit: 21 Aug 2026 (T+270)
Executives◇Options0Oslo
OSLO:657010·details not loaded
Executives●Purchase0Oslo
€43,548280,000 shares@ €0.1555
ShareXOSL
OSLO:657002·
Ideal exit: 7 Jul 2026 (T+270)
Executives●Purchase0Oslo
€8,59955,944 shares@ €0.1537
ShareXOSL
OSLO:656985·
Ideal exit: 7 Jul 2026 (T+270)
Executives◇Options0Oslo
OSLO:650976·details not loaded
Executives●Purchase0Oslo
€564,6623,000,000 shares@ €0.1882
ShareXOSL
OSLO:642414·
Ideal exit: 22 Dec 2025 (T+270)
Executives●Purchase0Oslo
€25,290100,000 shares@ €0.2529
ShareXOSL
OSLO:635453·
Ideal exit: 16 Sept 2025 (T+270)
Executives●Purchase0Oslo
€815,9515,000,000 shares@ €0.1632
ShareXOSL
OSLO:631746·
Ideal exit: 5 Aug 2025 (T+270)
Executives●Purchase0Oslo
€24,10350,000 shares@ €0.4821
ShareXOSL
OSLO:625848·
Ideal exit: 18 May 2025 (T+270)
Executives◇Options0Oslo
OSLO:622889·details not loaded
Executives●Purchase0Oslo
€32,20025,000 shares@ €1.288
ShareXOSL
OSLO:614682·
Ideal exit: 21 Dec 2024 (T+270)
Executives●Purchase0Oslo
€26,86620,311 shares@ €1.3227
ShareXOSL
OSLO:614248·
Ideal exit: 16 Dec 2024 (T+270)
Executives●Purchase0Oslo
€12,17910,000 shares@ €1.2179
ShareXOSL
OSLO:613304·
Ideal exit: 8 Dec 2024 (T+270)
Executives●Purchase0Oslo
€32,49925,000 shares@ €1.2999
ShareXOSL
OSLO:613028·
Ideal exit: 3 Dec 2024 (T+270)
Executives●Purchase0Oslo
€48,48740,000 shares@ €1.2122
ShareXOSL
OSLO:612998·
Ideal exit: 3 Dec 2024 (T+270)
Executives●Purchase0Oslo
€29,08120,000 shares@ €1.454
ShareXOSL
OSLO:612556·
Ideal exit: 29 Nov 2024 (T+270)
Executives●Purchase0Oslo
€8,7296,000 shares@ €1.4549
ShareXOSL
OSLO:612321·
Ideal exit: 25 Nov 2024 (T+270)
Executives●Purchase0Oslo
€14,2349,850 shares@ €1.4451
ShareXOSL
OSLO:602645·
Ideal exit: 27 Jul 2024 (T+270)
Executives●Purchase0Oslo
€27,67520,000 shares@ €1.3837
ShareXOSL
OSLO:602442·
Ideal exit: 23 Jul 2024 (T+270)
Executives●Purchase0Oslo
€684,445450,000 shares@ €1.521
ShareXOSL
OSLO:602118·
Ideal exit: 21 Jul 2024 (T+270)
Executives●Purchase0Oslo
€751,870500,000 shares@ €1.5037
ShareXOSL
OSLO:602096·
Ideal exit: 21 Jul 2024 (T+270)
25 of 52 declarations
